Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan

被引:32
作者
Okubo, M
Horinishi, A
Takeuchi, M
Suzuki, Y
Sakura, N
Hasegawa, Y
Igarashi, T
Goto, K
Tahara, H
Uchimoto, S
Omichi, K
Kanno, H
Hayasaka, K
Murase, T
机构
[1] Toranomon Gen Hosp, Dept Endocrinol & Metab, Minato Ku, Tokyo 1058470, Japan
[2] Okinaka Mem Inst Med Res, Tokyo, Japan
[3] Tokyo Womens Med Univ, Neurol Inst, Dept Neurol, Tokyo, Japan
[4] Toyohashi Municipal Hosp, Dept Pediat, Aichi, Japan
[5] Hiroshima Univ, Sch Med, Dept Pediat, Hiroshima, Japan
[6] Tokyo Metropolitan Kiyose Childrens Hosp, Endocrinol Metab & Genet Unit, Tokyo, Japan
[7] Hakujuji Gen Hosp, Dept Pediat, Ibaragi, Japan
[8] Osaka City Univ, Sch Med, Dept Pathol 2, Osaka 545, Japan
[9] Osaka City Univ, Sch Med, Dept Internal Med 2, Osaka 545, Japan
[10] Osaka Womens Univ, Fac Sci, Dept Environm Sci, Osaka, Japan
[11] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 99023, Japan
关键词
D O I
10.1007/s004390051017
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disorder caused by deficiency of the glycogen-debranching enzyme (AGL). Recent studies of the AGL gene have revealed the prevalent mutations in North African Jewish and Caucasian populations, but whether these common mutations are present in other ethnic groups remains unclear. We have investigated eight Japanese GSD IIIa patients fi om seven families and identified seven mutations, including one splicing mutation (IVS14+IG-->T) previously reported by us, together with six novel ones: a nonsense mutation (L124X), a splice site mutation (IVS29-1G-->C), a 1-bp deletion (587 delC), a 2-bp deletion (4216-4217 delAG), a 1-bp insertion (2072-2073 insA), and a 3-bp insertion (4735-4736 insTAT), The last mutation results in insertion of a tyrosine residue at a putative glycogen-binding site, and the rest are predicted to cause synthesis of truncated proteins lacking the glycogen-binding site at the carboxyl terminal. Thirteen novel polymorphisms have also been revealed in this study: three amino acid substitutions (R387Q, G1115R, and E1343 K), one silent point mutation (L298L), one nucleotide change in the 5'-noncoding region, and eight nucleotide changes in introns. Haplotype analysis with combinations of these polymorphic markers showed L124X, IVS14+1G-->T, and 3216-4217 delAG to be on different haplotypes. These results demonstrate the importance of the integrity of the carboxy terminal domain in the AGL protein and the molecular heterogeneity of GSD IIIa in Japan.
引用
收藏
页码:108 / 115
页数:8
相关论文
共 24 条
[11]  
NAKAYAMA A, 1998, BAA34996
[12]   A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III [J].
Okubo, M ;
Aoyama, Y ;
Murase, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :493-499
[13]   1176C Polymorphism in Japanese patients with glycogen storage disease type 1a [J].
Okubo, M ;
Horinishi, A ;
Murase, T ;
Hamada, K .
HUMAN GENETICS, 1999, 104 (02) :193-193
[14]   A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb [J].
Okubo, M ;
Horinishi, A ;
Nakamura, N ;
Aoyama, Y ;
Hashimoto, M ;
Endo, Y ;
Murase, T .
HUMAN GENETICS, 1998, 102 (01) :1-5
[15]  
Okubo M, 1997, CLIN GENET, V51, P179
[16]  
Omichi K, 1998, J BIOCHEM-TOKYO, V123, P932
[17]   A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients [J].
Parvari, R ;
Moses, S ;
Shen, JJ ;
Hershkovitz, E ;
Lerner, A ;
Chen, YT .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1997, 5 (05) :266-270
[18]   Two new mutations in the 3′ coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient [J].
Parvari, R ;
Shen, J ;
Hershkovitz, E ;
Chen, YT ;
Moses, SW .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (02) :141-148
[19]  
Shen JJ, 1997, HUM MUTAT, V9, P37, DOI 10.1002/(SICI)1098-1004(1997)9:1<37::AID-HUMU6>3.0.CO
[20]  
2-M